PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis
Advanced Science · 2024-10 · 11 (40)
DOI: 10.1002/advs.202403177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.08.2024. Verfasst von Wenxiang Chu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China. Hauptthemen laut MEDLINE: Glycolysis, Osteoclasts, Protein-Arginine N-Methyltransferases, Fatty Acids. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Projects of Shanghai Changzheng Hospital.
Abstract (Originalsprache)
Epigenetic regulation of metabolism profoundly influences cell fate commitment. During osteoclast differentiation, the activation of RANK signaling is accompanied by metabolic reprogramming, but the epigenetic mechanisms by which RANK signaling induces this reprogramming remain elusive. By transcriptional sequence and ATAC analysis, this study identifies that activation of RANK signaling upregulates PRMT6 by epigenetic modification, triggering a metabolic switching from fatty acids oxidation toward glycolysis. Conversely, Prmt6 deficiency reverses this shift, markedly reducing HIF‐1α‐mediated glycolysis and enhancing fatty acid oxidation. Consequently, PRMT6 deficiency or inhibitor impedes osteoclast differentiation and alleviates bone loss in ovariectomized (OVX) mice. At the molecular level, Prmt6 deficiency reduces asymmetric dimethylation of H3R2 at the promoters of genes including Ppard , Acox3 , and Cpt1a , enhancing genomic accessibility for fatty acid oxidation. PRMT6 thus emerges as a metabolic checkpoint, mediating metabolic switch from fatty acid oxidation to glycolysis, thereby supporting osteoclastogenesis. Unveiling PRMT6's critical role in epigenetically orchestrating metabolic shifts in osteoclastogenesis offers a promising target for anti‐resorptive therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
- Obstetrics and Gynecology Hospital, Fudan University, Shanghai, 200011, China.
- Histology and Embryology Department and Shanghai Key Laboratory of Cell Engineering, Naval Medical University, Shanghai, 200433, China.
- Department of Orthopaedics, Third Affiliated Hospital of Naval Medical University, Shanghai, 201805, China.
- National Key Laboratory of Immunity and Inflammation, Institute of Immunology, Naval Medical University, Shanghai, 200433, China.
ORCID-Profile: Xuhua Lu
Förderung
- National Natural Science Foundation of China
- Research Projects of Shanghai Changzheng Hospital
Zitieren
APA
Chu, W., Peng, W., Lu, Y., Liu, Y., Li, Q., Wang, H., Wang, L., Zhang, B., Liu, Z., Han, L., Ma, H., Yang, H., Han, C., & Lu, X. (2024). PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis. Advanced Science, 11(40). https://doi.org/10.1002/advs.202403177
Vancouver
Chu W, Peng W, Lu Y, Liu Y, Li Q, Wang H, et al. PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis. Advanced Science. 2024;11(40). doi:10.1002/advs.202403177
BibTeX
@article{Chu2024,
author = {Chu, Wenxiang and Peng, Weilin and Lu, Yingying and Liu, Yishan and Li, Qisheng and Wang, Haibin and Wang, Liang and Zhang, Bangke and Liu, Zhixiao and Han, Lin and Ma, Hongdao and Yang, Haisong and Han, Chaofeng and Lu, Xuhua},
title = {PRMT6 Epigenetically Drives Metabolic Switch from Fatty Acid Oxidation toward Glycolysis and Promotes Osteoclast Differentiation During Osteoporosis},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {40},
doi = {10.1002/advs.202403177}
}
EUVIMED